Completed PHASE1 INTERVENTIONAL 1-arm NCT00582946

Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding

Sponsor: EarLens Corporation

Interventions Hearing Aid

Updated 7 times since 2017 Last updated: Sep 30, 2016 Started: May 31, 2006 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hearing Impairment, this trial is completed. The trial is conducted by EarLens Corporation and has accumulated 7 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

EarLens Corporation
National Institute on Deafness and Other Communication Disorders (NIDCD)

Data source: EarLens Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Redwood City, United States